CVE-2023-6515 Mia Technology Inc. CVE debrief

Who should care

Security teams, application owners, and administrators running MIA-MED before 1.0.7 should prioritize this issue, especially if the application is exposed to untrusted users or integrated into sensitive clinical or operational workflows.

Technical summary

The vulnerability is described as an authorization bypass through a user-controlled key. Based on the NVD CVSS vector (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H), exploitation is network-reachable, requires low privileges, and can have high impact on confidentiality, integrity, and availability. USOM associates the issue with CWE-639, indicating an access-control weakness tied to improper authorization checks.

Defensive priority

High. This is a remotely reachable authorization flaw with high impact and a public advisory trail. Remediation should be treated as urgent for any affected MIA-MED deployment.

Recommended defensive actions

• Upgrade MIA-MED to version 1.0.7 or later.
• Review access-control and authorization logic around any user-controlled keys or identifiers.
• Audit logs for unexpected privilege use, account switching, or abnormal authorization failures.
• Restrict exposure of MIA-MED to trusted networks and authenticated administrative paths until patched.
• Validate that compensating controls do not rely on client-supplied values for authorization decisions.

Evidence notes

The vulnerability description and affected-version boundary come from the NVD CVE record and associated reference data. NVD lists the affected CPE range as MIA-MED versions before 1.0.7. USOM’s advisory is referenced in the NVD record and includes CWE-639. The record was published on 2024-02-08 and later modified on 2026-05-20; those dates reflect record timing, not remediation timing.

Official resources